NorthWest Biotherapeutics Inc (NWBO)

[Know-Fear]

The 80+ heads being added at Cognate are pure overhead and won't be "enriching" Cognate's bottom line unless they are producing product. 80 heads is quite an expansion outside of NW with "L" is it feasible that any of Cognate's other customers/partners could far enough along in trials with another labor intensive biologic product to be produced? 80 heads just smacks of commercialization.....

Mav, more a question for the board than for you. Thanks for the reply to my post vacation question about the screening halt possibly signifying full enrollment as I was certain it had to be considered by the rational faction and I didn't have the patience to weed through the irrational posts to find the nuggets.